Russia will charge less for the Sputnik V Covid-19 vaccine than its competitors as Moscow aims to produce more than one billion doses at home and abroad next year.
However, accurate price details are expected to be submitted later. Although the price is much cheaper than other vaccines but the level of effectiveness is the same.
Moscow, meanwhile, has faced criticism from some Western scientists who claim they are in a hurry to try the Sputnik V vaccine. Russia has therefore acted to deny the allegations.
In addition, the price of vaccines offered lower than competitors could help Moscow seize more market share.
In addition, RDIF and Gamaleya National Center revealed that new clinical trial data based on 39 confirmed cases of infection and a total of 18,794 patients receiving both vaccine dose injections have shown that Sputnik V is 91.4% effective on the 28th day and over 95% effective on the 42nd day.
